#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Gregory Fanning Email
Hepatitis B Program . AstriVax
Heverlee,
LocationPrimary Email
How to contact Gregory Fanning
Join and see Gregory's contact info for free!Current Roles
Employees:
40Revenue:
$6.2MAbout
AstriVax is a privately held spin-off company from the KU Leuven, founded in 2022 based on vaccine technology developed at the Rega Institute. AstriVax is building a first in class Plug & Play vaccine platform with a patented DNA based technology that launches self-amplifying live attenuated viruses. The versatile technology of AstriVax can be used to develop a wide range of vaccines to prevent and treat infectious diseases. AstriVax aims to address major challenges in vaccinology by developing novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various viruses and other pathogens.AstriVax Address
Heverlee, null
Belgium